DaVita HealthCare Partners Inc (DVA): Today's Featured Health Services Laggard

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

DaVita HealthCare Partners ( DVA) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 0.2%. By the end of trading, DaVita HealthCare Partners fell $1.75 (-1.5%) to $117.46 on average volume. Throughout the day, 1.1 million shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of one million shares. The stock ranged in price between $116.01-$118.50 after having opened the day at $118.47 as compared to the previous trading day's close of $119.21. Other companies within the Health Services industry that declined today were: Five Star Quality Care Incorporated ( FVE), down 14.4%, Fonar Corporation ( FONR), down 10.1%, EnteroMedics ( ETRM), down 7.6%, and InfuSystems Holdings ( INFU), down 7.4%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $11.33 billion and is part of the health care sector. The company has a P/E ratio of 21.5, above the S&P 500 P/E ratio of 17.7. Shares are up 7.4% year to date as of the close of trading on Thursday. Currently there are 10 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and three rate it a hold.

TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, revenue growth, notable return on equity and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

On the positive front, Bovie Medical Corporation ( BVX), up 11.8%, Mela ( MELA), up 6%, Allied Healthcare Products ( AHPI), up 5.7%, and NeoGenomics ( NEO), up 5.3%, were all gainers within the health services industry with Covidien ( COV) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

It's Official: Action Alerts PLUS beats the S&P 500 with Dividends Reinvested! Cramer and Link were up 16.72% in 2012. Were you? See what they are trading for 14-days FREE.
null

If you liked this article you might like

UnitedHealth Shares Jump on Fourth-Quarter Earnings Beat, Improved Guidance

UnitedHealth Shares Jump on Fourth-Quarter Earnings Beat, Improved Guidance

Are You Ready For a Correction?

Are You Ready For a Correction?

Aetna CEO to Receive $500 Million Once CVS Deal Closes: MARKETS LIVE

Aetna CEO to Receive $500 Million Once CVS Deal Closes: MARKETS LIVE

Dow and S&P 500 Decline, but Nasdaq Finishes Higher as Tech Recovers

Dow and S&P 500 Decline, but Nasdaq Finishes Higher as Tech Recovers

3 Things You Must Know About Wall Street as You Head to Lunch

3 Things You Must Know About Wall Street as You Head to Lunch